Leap Therapeutics Stock Operating Margin
| LPTXDelisted Stock | USD 2.05 1.61 365.91% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Leap Therapeutics' long-term financial health and intrinsic value.
Leap |
Leap Therapeutics Company Operating Margin Analysis
Leap Therapeutics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Leap Therapeutics has an Operating Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Leap Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Leap Therapeutics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Leap Therapeutics could also be used in its relative valuation, which is a method of valuing Leap Therapeutics by comparing valuation metrics of similar companies.Leap Therapeutics is currently under evaluation in operating margin category among its peers.
Leap Fundamentals
| Return On Equity | -1.84 | ||||
| Return On Asset | -0.77 | ||||
| Current Valuation | 98.05 M | ||||
| Shares Outstanding | 56.65 M | ||||
| Shares Owned By Insiders | 11.91 % | ||||
| Shares Owned By Institutions | 28.72 % | ||||
| Number Of Shares Shorted | 2.91 M | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 20.31 X | ||||
| Price To Sales | 160.10 X | ||||
| Gross Profit | 1.5 M | ||||
| EBITDA | (70.05 M) | ||||
| Net Income | (67.56 M) | ||||
| Cash And Equivalents | 90.88 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 266 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.88 X | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (60.3 M) | ||||
| Short Ratio | 0.42 X | ||||
| Earnings Per Share | (1.58) X | ||||
| Price To Earnings To Growth | 0.75 X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 52 | ||||
| Beta | 0.086 | ||||
| Market Capitalization | 116.14 M | ||||
| Total Asset | 49.12 M | ||||
| Retained Earnings | (467.37 M) | ||||
| Working Capital | 33.96 M | ||||
| Current Asset | 2.38 M | ||||
| Current Liabilities | 22.01 M | ||||
| Net Asset | 49.12 M |
About Leap Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Leap Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Leap Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Leap Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Leap Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Leap Stock
If you are still planning to invest in Leap Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Leap Therapeutics' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |